Dr. Jay Sengupta

Jay Sengupta, MD, FACC, FHRS

Director, Joseph F. Novogratz Family Heart Rhythm Center

Dr. Sengupta is a graduate of Texas Tech University Health Sciences Center School of Medicine and completed residency training in Internal Medicine at Barnes-Jewish Hospital/Washington University in St. Louis. He did his Fellowship training in Cardiology and subsequently Cardiac Electrophysiology at the Cleveland Clinic. 

Dr. Sengupta is board certified in Cardiac Electrophysiology; he specializes in the treatment of arrhythmias and performs procedures including catheter ablation and cardiac rhythm device implantation and management. He is Director of the Joseph F. Novogratz Family Heart Rhythm Center at the Minneapolis Heart Institute Foundation where the mission is to improve care for patients with heart rhythm disorders through innovation and research that advances the field of cardiac electrophysiology.

He is Director of the Minneapolis Heart Institute Genetic Arrhythmia Center and Co-Director of the Cardiac Pacing and Device Clinic at Abbott Northwestern Hospital (ANW). He is involved in educating future cardiologists and physicians as faculty in the Hennepin County Medical Center/MHI Cardiovascular Disease Fellowship and a yearly mentor for MHI summer research interns. 

Recent awards include the Ray Bentdahl MHIF Distinguished Service Award, Distinguished Teaching Award in the Hennepin County Medical Center/MHI Cardiovascular Disease Fellowship, and Rising Star/Top Docs in MPLS. St. Paul Magazine.

Back to Heart Rhythm Team

Dr. Jay Sengupta
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.